Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Related Articles by Review for PubMed (Select 2661600)

1.

Long-term efficacy and toxicity of high- and low-dose amiodarone regimens.

Kerin NZ, Aragon E, Faitel K, Frumin H, Rubenfire M.

J Clin Pharmacol. 1989 May;29(5):418-23. Review.

PMID:
2661600
2.

Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.

Singh BN.

Am J Cardiol. 1996 Aug 29;78(4A):41-53. Review.

PMID:
8780328
3.

Low-dose amiodarone should not be the first-line treatment for atrial fibrillation.

Sung RJ.

Cardiovasc Drugs Ther. 1994 Oct;8(5):773-4. Review.

PMID:
7873476
4.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
5.

Practical follow-up guidelines for patients treated with amiodarone.

Podrid PJ.

Clin Cardiol. 1987 Jul;10(7 Suppl 1):I10-6. Review.

PMID:
3078154
6.

Amiodarone: a unique antiarrhythmic agent.

Sloskey GE.

Clin Pharm. 1983 Jul-Aug;2(4):330-40. Review.

PMID:
6349912
7.

The role of intravenous amiodarone in the management of cardiac arrhythmias.

Desai AD, Chun S, Sung RJ.

Ann Intern Med. 1997 Aug 15;127(4):294-303. Review.

PMID:
9265430
8.

Low-dose amiodarone for atrial fibrillation.

Middlekauff HR, Wiener I, Stevenson WG.

Am J Cardiol. 1993 Nov 26;72(16):75F-81F. Review.

PMID:
8237834
9.
10.

Optimal management of amiodarone therapy: efficacy and side effects.

Hilleman D, Miller MA, Parker R, Doering P, Pieper JA.

Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):138S-145S. Review.

PMID:
9855346
11.

A general overview of amiodarone toxicity: its prevention, detection, and management.

Vrobel TR, Miller PE, Mostow ND, Rakita L.

Prog Cardiovasc Dis. 1989 May-Jun;31(6):393-426. Review.

PMID:
2652188
12.

Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.

Zipes DP, Prystowsky EN, Heger JJ.

J Am Coll Cardiol. 1984 Apr;3(4):1059-71. Review.

PMID:
6368644
13.

Oral amiodarone: historical overview and development.

Pollak PT.

Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):121S-126S. Review.

PMID:
9855344
14.

Amiodarone and post-MI patients.

Nademanee K, Singh BN, Stevenson WG, Weiss JN.

Circulation. 1993 Aug;88(2):764-74. Review.

PMID:
7687937
15.

Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations.

Pollak PT.

Am J Cardiol. 1999 Nov 4;84(9A):37R-45R. Review.

PMID:
10568658
16.

[Long-term efficacy and tolerability of amiodarone in children].

Bosser G, Marçon F, Lethor JP, Worms AM.

Arch Mal Coeur Vaiss. 1995 May;88(5):731-6. Review. French.

PMID:
7646285
17.

Serious adverse effects of amiodarone.

McGovern B, Garan H, Ruskin JN.

Clin Cardiol. 1984 Mar;7(3):131-7. Review.

PMID:
6368073
18.

The novel antiarrhythmic drug dronedarone: comparison with amiodarone.

Kathofer S, Thomas D, Karle CA.

Cardiovasc Drug Rev. 2005 Fall;23(3):217-30. Review.

PMID:
16252015
19.

An overview of antiarrhythmic drug management of electrical storm.

Kowey PR.

Can J Cardiol. 1996 Apr;12 Suppl B:3B-8B; discussion 27B-28B. Review.

PMID:
8616726
20.

Amiodarone: an emergency medicine perspective.

Taylor SE.

Emerg Med (Fremantle). 2002 Dec;14(4):422-9. Review.

PMID:
12534486
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk